Protas announces collaboration with GSK to advise on optimising protocol development
Protas has formed a multi-year strategic collaboration with GlaxoSmithKline (GSK) to advise on the development of clinical trial protocols across a range of different late-phase investigational products. Leveraging the Protas team’s vast experience in designing and delivering clinical trials, GSK has engaged Protas to provide valuable complementary expertise and strategic insights to the development of … Continued